Status:
UNKNOWN
Skin Disease in Methamphetamine Abuse
Lead Sponsor:
Assiut University
Conditions:
Methamphetamine Abuse
Eligibility:
All Genders
14-75 years
Brief Summary
1\. To detect the skin diseases in patients using methamphetamine
Detailed Description
Methamphetamine is a stimulant drug that associated with a broad spectrum of health conditions, include addiction, mental health disorders, and overdose. The Drug Enforcement Agency (DEA) classifies i...
Eligibility Criteria
Inclusion
- Patients using methamphetamine
Exclusion
- 1\. Pregnant and lactating patients. 2. Patients with chronic diseases
Key Trial Info
Start Date :
August 3 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 20 2024
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT05971043
Start Date
August 3 2023
End Date
September 20 2024
Last Update
August 2 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.